Pulsenmore (XTAE:PULS) Total Receivables : ₪4.56 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pulsenmore Total Receivables?

Pulsenmore's Total Receivables for the quarter that ended in Dec. 2024 was ₪4.56 Mil.

Pulsenmore Total Receivables Historical Data

The historical data trend for Pulsenmore's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsenmore Total Receivables Chart

Pulsenmore Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Receivables

Get a 7-Day Free Trial

0.28

5.33

11.37

1.89

4.56

Pulsenmore Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Receivables	Get a 7-Day Free Trial						11.37	5.07	1.89	4.44	4.56

Pulsenmore Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Pulsenmore Total Receivables Related Terms

Thank you for viewing the detailed overview of Pulsenmore's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulsenmore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsenmore Ltd (XTAE:PULS) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Omarim 8, Omar, ISR, 8496500

Website

https://www.pulsenmore.com

Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.